Mitsubishi Tanabe Pharma <4508.T>-2008/09 parent

May 8 (Reuters) -

MITSUBISHI TANABE PHARMA CORP

PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010

LATEST YEAR-AGO COMPANY

RESULTS RESULTS FORECASTS
Sales 367.66 269.07
Operating 68.67 49.08
Recurring 73.89 52.15
Net 31.80 23.52
EPS Y56.67 Y58.48
Annual div Y28.00 Y20.68 Y28.00
-Q2 div Y14.00 Y14.00
-Q4 div Y14.00 Y13.00 Y14.00

NOTE - Mitsubishi Tanabe Pharma Corp is a leading drug maker with strength in drugs
for circulatory system.

If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

For latest earnings estimates made by Toyo Keizai, please
double click on 4508.TK1.